MEDIA STATEMENT
29th May 2009

ASPIRIN FOR VASCULAR EVENTS

The Aspirin Foundation has seen and wishes to comment on the study by the authoritative Oxford University Trialists' Collaboration Group.

The Foundation continues to recommend that people considering the use of aspirin for primary prevention of vascular events do so in consultation with their doctor.

This discussion between doctor and patient allows for individual risk assessment based on general health, family history and other risk factors for cardiovascular disease. This consultative time with the doctor can also allow for counsel on lifestyle modification to improve overall health.

The value of aspirin in secondary prevention is well established and uncontroversial.